Literature DB >> 28216333

Vitamin D receptor gene polymorphisms, smoking, and risk of sporadic Parkinson's disease in Japan.

Keiko Tanaka1, Yoshihiro Miyake2, Wakaba Fukushima3, Chikako Kiyohara4, Satoshi Sasaki5, Yoshio Tsuboi6, Tomoko Oeda7, Hiroyuki Shimada8, Nobutoshi Kawamura9, Nobutaka Sakae10, Hidenao Fukuyama11, Yoshio Hirota12, Masaki Nagai13, Yoshikazu Nakamura14.   

Abstract

Epidemiological evidence on the relationships between the vitamin D receptor (VDR) single nucleotide polymorphisms (SNPs) rs731236 (TaqI), rs7975232 (ApaI), rs1544410 (BsmI), and rs2228570 (FokI) and Parkinson's disease (PD) is inconsistent. We investigated these relationships in 229 sporadic PD patients within six years of onset in Japan. Controls were 357 patients without neurodegenerative disease. Adjustment was made for sex, age, region of residence, and smoking. A significant inverse association was found between SNP rs2228570 and the risk of sporadic PD under the additive but not the co-dominant or dominant model (P=0.048); however, this fell below significance after adjustment for multiple comparisons (adjusted P=0.46). No significant relationships were found between SNPs rs731236, rs7975232, or rs1544410 and the risk of sporadic PD in any genetic model. VDR haplotypes inferred in the current study were not associated with sporadic PD. Compared with subjects with the GA or AA genotype of SNP rs2228570 who had ever smoked, those with the GG genotype who had never smoked had a 3.78-fold increased risk of sporadic PD; however, no significant interaction was observed. VDR SNP rs2228570 may be associated with sporadic PD in Japan. Smoking did not significantly modify the relationship between SNP rs2228570 and sporadic PD.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Case-control study; Gene-environment interaction; Japanese; Parkinson’s disease; Smoking; VDR polymorphisms

Mesh:

Substances:

Year:  2017        PMID: 28216333     DOI: 10.1016/j.neulet.2017.02.037

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  4 in total

Review 1.  Vitamin D and Neurological Diseases: An Endocrine View.

Authors:  Carolina Di Somma; Elisabetta Scarano; Luigi Barrea; Volha V Zhukouskaya; Silvia Savastano; Chiara Mele; Massimo Scacchi; Gianluca Aimaretti; Annamaria Colao; Paolo Marzullo
Journal:  Int J Mol Sci       Date:  2017-11-21       Impact factor: 5.923

2.  No Vitamin D Deficiency in Patients with Parkinson's Disease.

Authors:  Wilfried Kuhn; Georg Karp; Thomas Müller
Journal:  Degener Neurol Neuromuscul Dis       Date:  2022-09-26

3.  Association Between Serum Vitamin D Levels and Parkinson's Disease: A Systematic Review and Meta-Analysis.

Authors:  Xiaoyue Luo; Ruwei Ou; Rajib Dutta; Yuan Tian; Hai Xiong; Huifang Shang
Journal:  Front Neurol       Date:  2018-11-12       Impact factor: 4.003

Review 4.  The relationships of vitamin D, vitamin D receptor gene polymorphisms, and vitamin D supplementation with Parkinson's disease.

Authors:  Lingling Lv; Xuling Tan; Xinke Peng; Rongrong Bai; Qile Xiao; Ting Zou; Jieqiong Tan; Hainan Zhang; Chunyu Wang
Journal:  Transl Neurodegener       Date:  2020-09-01       Impact factor: 8.014

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.